Mycophenolate mofetil (CellCept) was as effective as cyclophosphamide for remission induction in antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis, Japanese researchers reported. In a ...
Objective The aim of this study was to investigate the relationship between antineutrophil cytoplasmic antibodies (ANCA) ...
Pivotal trial demonstrated avacopan’s statistical superiority in sustaining remission at 52 weeks over the glucocorticoid-containing standard-of-care therapy MOUNTAIN VIEW, Calif., June 03, 2020 ...
In this randomized, controlled trial, we assigned patients with ANCA-associated vasculitis in a 1:1 ratio to receive oral avacopan at a dose of 30 mg twice daily or oral prednisone on a tapering ...
ST. GALLEN, Switzerland & MOUNTAIN VIEW, Calif.--(BUSINESS WIRE)--Regulatory News: Vifor Fresenius Medical Care Renal Pharma (VFMCRP) and ChemoCentryx, Inc., (NASDAQ:CCXI) today announced positive ...
MedPage Today on MSN
Eye Issues Common With ANCA-Associated Vasculitis
Newer data show prevalence, treatment outcomes ...
ANCAs are mainly IgG in nature. These are specific autoantibodies. Thus they are antibodies produced by the immune system that mistakenly target the individual’s own proteins. They are directed ...
Prophylactic treatment with trimethoprim-sulfamethoxazole (TMP-SMX) significantly reduced the risk for serious infections by approximately 50% in patients with antineutrophil cytoplasmic antibody ...
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. SAN DIEGO — Approximately two-thirds of patients with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback